NCT07248046 Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
| NCT ID | NCT07248046 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bruyère Health Research Institute. |
| Condition | Fertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2026-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-01-15 with a primary completion date of 2026-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \[LH\], pregnanediol glucuronide \[PDG\], and basal body temperature \[BBT\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.
Eligibility Criteria
Inclusion Criteria: * Female, aged 16 to 45 * Natural menstrual cycles equal or less than 35 days * Off hormonal contraception for more than 3 months * Current user of the Premom App * Willing to track cervical mucus, LH, PDG, and BBT for 3 full cycles * Lives within 50 km of study site in the Ottawa region * Able to provide informed consent Exclusion Criteria: * Pregnant or breastfeeding * Current hormonal therapy or contraception * Known anovulatory disorders, e.g., Polycystic Ovary Syndrome, hypothalamic amenorrhea. * Very irregular or absent cycles * Not using the Premom App * Unable or unwilling to complete tracking or provide consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07248046 clinical trial?
This trial is open to female participants only, aged 16 Years or older, up to 45 Years, studying Fertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07248046 currently recruiting?
Yes, NCT07248046 is actively recruiting participants. Contact the research team at rleiva@bruyere.org for enrollment information.
Where is the NCT07248046 trial being conducted?
This trial is being conducted at Ottawa, Canada.
Who is sponsoring the NCT07248046 clinical trial?
NCT07248046 is sponsored by Bruyère Health Research Institute.. The trial plans to enroll 30 participants.